Use of biologics in the treatment of childhood rheumatic diseases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s11926-000-0071-1.pdf
Reference53 articles.
1. Laxer RM: Long-term toxicity of immune suppression in juvenile rheumatic diseases. Rheumatology 1999, 38:743–746. This article gives the details in immunosuppressive agent toxicity in the treatment of childhood rheumatic diseases and insights in the need for safety with better efficacy agents.
2. Petty RE: Prognosis in children with rheumatic diseases: justification for consideration of new therapies. Rheumatology 1999, 38:739–742.
3. Lovell DJ, Giannini EH, Reiff A, et al.: Etanercept in children with polyarticular juvenile rheumatoid arthritis: Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000, 342(11):763–769. This article is the first collaborative study that evaluates the safety and efficacy of etanercept in polyarticular JIA. The study involved 69 patients with polyarthritis of any types and showed significant improvement in patients with active polyarticular JIA and the agent was well tolerated with mild side effects.
4. Petty RE, Southwood TR, Baum J, et al.: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998, 25(10):1991–1994.
5. Prieur AM, Kaufmann MT, Griscelli C, et al.: Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 1987, 2(8570):1240–1242.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. How do I ensure safe use of biological agents in children and adolescents with rheumatic diseases?;Paediatrics and Child Health;2014-06
2. Biologics in children’s autoimmune disorders: efficacy and safety;European Journal of Pediatrics;2010-06-17
3. CHRONIC ARTHRITIS IN CHILDHOOD;Textbook of Pediatric Rheumatology;2005
4. Current treatment for chronic arthritis in childhood;Current Opinion in Pediatrics;2002-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3